Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
52,223,325
-
Total 13F shares
-
1,032,562
-
Share change
-
+1,032,562
-
Total reported value
-
$3,003,000
-
Price per share
-
$2.91
-
Number of holders
-
7
-
Value change
-
+$3,003,000
-
Number of buys
-
7
Institutional Holders of DiaMedica Therapeutics Inc. - Common Shares, no par value (DMAC) as of Q4 2018
As of 31 Dec 2018,
DiaMedica Therapeutics Inc. - Common Shares, no par value (DMAC) was held by
7 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,032,562 shares.
The largest 7 holders included
WEXFORD CAPITAL LP, G2 Investment Partners Management LLC, Manatuck Hill Partners, LLC, Worth Venture Partners, LLC, BANK OF AMERICA CORP /DE/, UBS Group AG, and ROYAL BANK OF CANADA.
This page lists
7
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.